The Global Intravenous Immunoglobulin Market Size is expected to grow from USD 16.5billion in 2025 to USD 36.1billion by 2035, at a CAGR of 8.14% during the forecast period 2026-2035.
The Global Intravenous Immunoglobulin (IVIG) Market refers to a business sector that focuses on producing, selling, and using intravenous immunoglobulin for treating immune deficiency diseases, autoimmune disorders, and neurological diseases.
This comprehensive market research report provides an in-depth analysis of the Intravenous Immunoglobulin market, with a focused evaluation of industry developments through 2025. The study delivers detailed insights into current market dynamics, emerging trends, growth drivers, competitive landscape, future strategic outlook, and the evolving regulatory key segments.
The Global Intravenous Immunoglobulin Market Report identifies emerging business opportunities while supporting informed strategic and tactical decision-making. Designed for stakeholders operating in a highly competitive and rapidly evolving landscape, this study delivers up-to-date market intelligence essential for tracking performance, mitigating risks, and driving sustainable growth and profitability.
Key Players in Global Intravenous Immunoglobulin Market
- CSL Behring
- Grifols S.A.
- Takeda Pharmaceutical Company Limited
- Octapharma AG
- Kedrion Biopharma
- Biotest AG
- Baxter International Inc.
- LFB Group
- China Biologic Products Holdings Inc.
- ADMA Biologics Inc.
- Bio Products Laboratory Ltd.
- Shanghai RAAS Blood Products Co., Ltd
Our expert team is consistently working on updated data and information on the key player's related business processes that value the market for future strategies and predictions
Get Access to a Free Copy of Our Latest Sample Report - https://www.decisionsadvisors.com/request-sample/DAR4761
Market Segmentation:
By Product Type
- IgG
- IgA
- IgM
- IgD
- IgE
By Application
- Immunodeficiency diseases
- Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Myasthenia Gravis, Multifocal Motor Neuropathy
- Idiopathic Thrombocytopenic Purpura (ITP)
- Inflammatory Myopathies
- Guillain-Barre Syndrome
Key Insights Covered in the Global Intravenous Immunoglobulin Market Size & Industry Forecast Report (2020–2035):
1. Detailed analysis of the Global Intravenous Immunoglobulin Market Size, production capacity, utilization rate, output trends, capital investment patterns, and regulatory landscape, along with comprehensive profiles of leading market players.
2. Thorough assessment of Intravenous Immunoglobulin Market Growth, revenue analysis, historical performance, and forward-looking projections across major regional markets.
3. In-depth Intravenous Immunoglobulin Industry Analysis covering competitive landscape, company market share, pricing trends, and future opportunity mapping.
4. Strategic evaluation of recent developments including mergers & acquisitions, partnerships, collaborations, joint ventures, geographic expansions, and product launches shaping the Intravenous Immunoglobulin Market Share.
5. Comprehensive value chain and supply chain analysis highlighting raw material sourcing, distribution channels, and end-user segmentation.
6. Regional regulatory framework assessment and policy impact analysis influencing the Intravenous Immunoglobulin Industry Forecast across North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.
7. Coverage of technological advancements, product innovations, R&D investments, automation trends, and digital transformation influencing long-term Global Intravenous Immunoglobulin Market Growth.
Buy this report now:- https://www.decisionsadvisors.com/checkout/select-licence?report_id=DAR4761
Industry Developments:
In April 2026, GC Biopharma enhanced the safety profile of its intravenous immunoglobulin (IVIG) products by introducing advanced prothrombotic impurity detection technology. The company developed an improved assay to accurately detect Factor XI, reduce thromboembolic risks, and strengthen quality control while aligning with evolving global regulatory standards.
In March 2025, ADMA Biologics Inc responded to a short-selling report, stating that it had distorted facts and created confusion about the actual efficacy and competitive position of its IVIG product, Asceniv, while reaffirming confidence in the therapy’s performance and market standing.
Regional Analysis for Intravenous Immunoglobulin Market:
✫ North America: (U.S., Canada, Mexico)
✫ Europe: (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
✫ Asia-Pacific: (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
✫ South America: (Colombia, Brazil, Argentina, Rest of South America)
✫ Middle East & Africa: (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Benefits of the Report:
⏩ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.
⏩ Top-down and bottom-up approach for regional analysis
⏩ Porter’s five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players.
⏩ By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Market
Frequently asked questions:
➥ What is the market size of the Intravenous Immunoglobulin market?
➥ What is the market growth rate of the Intravenous Immunoglobulin market?
➥ What are the Intravenous Immunoglobulin market opportunities and threats faced by the vendors in the global Intravenous Immunoglobulin Industry?
➥ Which application/end-user or product type may seek incremental growth prospects? What is the market share of each type and application?
➥ What focused approach and constraints are holding the Intravenous Immunoglobulin market?
➥ What are the different sales, marketing, and distribution channels in the global industry?
Unlock the full report now! @ https://www.decisionsadvisors.com/reports/intravenous-immunoglobulin-market
About the Decisions Advisors
Decisions Advisors is a comprehensive market research and consulting company that provides actionable insights based on data. We deal with businesses from various industries and deliver a market intelligence, competitive analysis, forecasting, and bespoke consulting. We also conduct bespoke consulting for our clients.
We provides well-supported advice and intelligence on how businesses can operate in a given market and succeed in achieving their goals.
Contact Us:
Company Name: Decision Advisors
Email: [email protected]
Phone: +1 303 800 4326 (US)
